Back to Journals » OncoTargets and Therapy » Volume 9

Original Research

Dendritic cell immunotherapy versus bevacizumab plus irinotecan in recurrent malignant glioma patients: a survival gain analysis

       
Total article views   HTML views PDF downloads Totals
6,877 Dovepress* 6,181+ 914 7,095
PubMed Central* 696 168 864
Totals 6,877 1,082 7,959
*Since 4 November 2016

View citations on PubMed Central and Google Scholar